Friday, 30 September 2016

Eye Specialist in London Offers Treatment for MGD Using E-Eye Device

Mr. Samer Hamada, a renowned eye specialist in London is offering treatment for dry eye syndrome caused by Meibomian gland dysfunction (MGD) using the revolutionary E-Eye device. Currently, there are no preventative treatments for dry eye. Until the introduction of E-Eye, patients can only achieve short-term relief through artificial eye drops. Now, with this device, dry eye sufferers can benefit from long-lasting relief.

Dry eye syndrome is a common disease that affects up to 30 per cent of certain adult groups. According to research, senior are most at risk of contracting the disease. Meanwhile, females have a greater prevalence for it than males.

Tuesday, 27 September 2016

Eye Clinic London: First in the UK to Use E-Eye Device for Treatments

Eye Clinic London proudly announces that they are the very first clinic in the UK to have the E-Eye device. The E-Eye is a groundbreaking medical device, the only one in the world that uses Intense Regulated Pulsed Light (IRPL). Specifically designed for treating dry eye diseases caused by Meibomian gland dysfunction (MGD), the technology behind the E-Eye offers long term relief for patients.

Using the IRPL technology, the E-Eye device generates polychromatic pulses. Each flash of light released is delivered under the shape of train pulses and targets treatment areas like the cheekbone and the temple around the eye. Here, the nerve branches connected to the Meibomian gland nerve and affected by dry eye disease are located. The train of pulse then creates a micro gradient of temperature between the inner and outer layer of the myelin sheath and triggers the liberation of neurotransmitters.

Wednesday, 7 September 2016

An Eye Doctor Offers the Treatment of Keratoconus with Contact Lenses

Eye conditions are so varied that it can be hard to keep up with all the things that could go wrong with our vision care, and that is why regular exams are advisable. Keratoconus is one condition that an eye surgeon can treat before it progresses further.

The eye disease causes thinning of the naturally round-shaped cornea into a cone-like bulge. A cornea with such a shape leads to distorted vision because light deflects when it hits the sides of the cornea. The condition is progressive with the shape of the cornea getting more irregular, resulting in astigmatism and near-sightedness.

It is not clear what causes the condition, but some genetic predispositions such as asthma have shown susceptibility to keratoconus.